Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.262 SEK | +0.77% | +4.38% | -3.32% |
24/05 | Xintela AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
23/05 | Xintela and EQGen Biomedical to Collaborate to Develop EQSTEM Stem Cell Treatment for Horses | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.39Cr | - | - | - | - | - | |
6.39TCr | - | |||||
4.18TCr | ||||||
4.05TCr | ||||||
2.72TCr | ||||||
2.65TCr |
- Stock Market
- Equities
- XINT Stock
- Charts Xintela AB
- Sector Chart